Advanced search
Publication Cover
Leukemia & Lymphoma Volume 46, 2005 - Issue 4
Submit an article Journal homepage
181
Views
32
CrossRef citations to date
0
Altmetric
Original Article

R-CHOP-14 in patients with diffuse large B-cell lymphoma: Feasibility and preliminary efficacy

Jeffrey L Halaas Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USACorrespondence[email protected]
,
Craig H Moskowitz Developmental Chemotherapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA
,
Steven Horwitz Radiation Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA
,
Carol Portlock Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA
,
Ariela Noy Developmental Chemotherapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA
,
David Straus Radiation Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA
,
Owen A O'Connor Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA
,
Joachim Yahalom Developmental Chemotherapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA
&
Andrew D Zelenetz Radiation Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA
 show all
Pages 541-547 | Received 11 Nov 2004, Published online: 03 Aug 2009

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Thomas M Habermann. (2012) New developments in the management of diffuse large B-cell lymphoma. Hematology 17:sup1, pages s93-s97.
Read now
M. Christina Cox, Vincenzo Ambrogi, Valerio Lanni, Elena Cavalieri, Sabrina Pelliccia, Francesco Scopinaro, Bruno Monarca, Paolo Marchetti & M. Antonietta Aloe Spiriti. (2012) Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy. Leukemia & Lymphoma 53:2, pages 263-269.
Read now
Dorte Tholstrup, Peter De nully brown, Jesper Jurlander, Palle Bekker jeppesen & Mogens Groenvold. (2011) Quality of life in patients with diffuse large B-cell lymphoma treated with dose-dense chemotherapy is only affected temporarily. Leukemia & Lymphoma 52:3, pages 400-408.
Read now
Maria Christina Cox, Italo Nofroni, Luigi Ruco, Rachele Amodeo, Antonella Ferrari, Giacinto La Verde, Patrizia Cardelli, Enrico Montefusco, Esmeralda Conte, Bruno Monarca & Maria Antonietta Aloe-Spiriti. (2008) Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma. Leukemia & Lymphoma 49:9, pages 1745-1751.
Read now

Articles from other publishers (28)

Cong Li, Fangxiao Lu, Tao Lei, Haifeng Yu, Xi Chen, Shuailing Peng, Shuiyun Han & Haiyan Yang. (2020) Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy. BMC Cancer 20:1.
Crossref
Marilia Barreca, Anastasios Stathis, Paola Barraja & Francesco Bertoni. (2020) An overview on anti-tubulin agents for the treatment of lymphoma patients. Pharmacology & Therapeutics 211, pages 107552.
Crossref
Marijke Linschoten, Janine A M Kamphuis, Anna van Rhenen, Laurens P Bosman, Maarten J Cramer, Pieter A Doevendans, Arco J Teske & Folkert W Asselbergs. (2020) Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis. The Lancet Haematology 7:4, pages e295-e308.
Crossref
Mehrdad Payandeh, Safa Najafi, Fateme-Zahra Shojaiyan & Masoud Sadeghi. (2016) Phase III of Study of R-CHOP-21 vs R-CHOP-14 for Untreated Stage III and IV B-cell Non-Hodgkin's Lymphoma: a Report from Iran. Asian Pacific Journal of Cancer Prevention 17:3, pages 1513-1517.
Crossref
OSAMU SUZUKI, MASAFUMI ABE & YUKO HASHIMOTO. (2015) Caspase-dependent drug-induced apoptosis is regulated by cell surface sialylation in human B-cell lymphoma. Oncology Letters 10:2, pages 687-690.
Crossref
Richard Delarue, Hervé Tilly, Nicolas Mounier, Tony Petrella, Gilles Salles, Catherine Thieblemont, Serge Bologna, Hervé Ghesquières, Maya Hacini, Christophe Fruchart, Loïc Ysebaert, Christophe Fermé, Olivier Casasnovas, Achiel Van Hoof, Antoine Thyss, Alain Delmer, Olivier Fitoussi, Thierry Jo Molina, Corinne Haioun & André Bosly. (2013) Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial. The Lancet Oncology 14:6, pages 525-533.
Crossref
Jeong Eun KimDok Hyun YoonGeundoo JangDae Ho LeeShin KimChan-Sik ParkJooryung HuhWon Seog KimJinny ParkJae Hoon LeeSoon Il LeeCheolwon Suh. (2012) A phase I/II study of bortezomib plus CHOP every 2 weeks (CHOP-14) in patients with advanced-stage diffuse large B-cell lymphomas. The Korean Journal of Hematology 47:1, pages 53.
Crossref
Manuel Gotti, Valeria Fiaccadori & Ercole Brusamolino. (2011) Diffuse large B-cell lymphoma: update on therapy and prognosis. Clinical Investigation 1:7, pages 989-997.
Crossref
Catharyn J. STERN, Manuela G. TOLEDO, Lyndon G. HALE, Debra A. GOOK & David H. EDGAR. (2011) The first Australian experience of heterotopic grafting of cryopreserved ovarian tissue: evidence of establishment of normal ovarian function. Australian and New Zealand Journal of Obstetrics and Gynaecology 51:3, pages 268-275.
Crossref
Pamela Drullinsky, Steven M. Sugarman, Monica N. Fornier, Gabriella D'Andrea, Teresa Gilewski, Diana Lake, Tiffany Traina, Carolyn Wasserheit-Lieblich, Nancy Sklarin, Deena Atieh-Graham, Nancy Mills, Tiffany Troso-Sandoval, Andrew D. Seidman, Jeffrey Yuan, Hamangi Patel, Sujata Patil, Larry Norton & Clifford Hudis. (2010) Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer. Clinical Breast Cancer 10:6, pages 440-444.
Crossref
Francesca Cainelli, Matthew N Tanko & Sandro Vento. (2010) The challenge of lymphomas in sub-Saharan Africa. The Lancet Oncology 11:7, pages 610-611.
Crossref
Thomas M. Habermann. (2010) ASH 2009 meeting report—Top 10 clinically oriented abstracts in lymphoma. American Journal of Hematology 85:4, pages 280-283.
Crossref
Lynnette K Tumwine, Claudio Agostinelli, Cristina Campidelli, Emmanuel Othieno, Henry Wabinga, Simona Righi, Brunangelo Falini, Pier Paolo Piccaluga, Wilson Byarugaba & Stefano A Pileri. (2009) Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda. BMC Clinical Pathology 9:1.
Crossref
David Aguiar Bujanda, José Aguiar Morales, Uriel Bohn Sarmiento, Salvador Saura Grau & Carlos Rodríguez Franco. (2009) Clinical experience with biweekly CHOP plus rituximab chemoimmunotherapy for the treatment of aggressive B-cell non-Hodgkin lymphoma. Clinical and Translational Oncology 11:9, pages 604-608.
Crossref
Robert O. Dillman. 2009. Principles of Cancer Biotherapy. Principles of Cancer Biotherapy 303 406 .
Pieternella J. Lugtenburg & Pieter Sonneveld. (2008) Treatment of diffuse large B-cell lymphoma in the elderly: Strategies integrating oncogeriatric themes. Current Oncology Reports 10:5, pages 412-419.
Crossref
John P. Leonard, Peter Martin, Jacqueline Barrientos & Rebecca Elstrom. (2008) Targeted Treatment and New Agents in Diffuse Large B-Cell Lymphoma. Seminars in Hematology 45, pages S11-S16.
Crossref
Ercole BrusamolinoMargherita MaffioliMaurizio BonfichiUmberto Vitolo. (2008) Front-line therapy for nonlocalized diffuse large B-cell lymphoma: what has been demonstrated and what is yet to be established. Future Oncology 4:2, pages 199-210.
Crossref
. (2008) Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin’s lymphoma. European Journal of Haematology 80:3, pages 275-276.
Crossref
Ercole Brusamolino. (2008) Managing the myelotoxicity of CHOP chemotherapy. European Journal of Cancer Supplements 6:2, pages 31-36.
Crossref
Antonio Rueda, Pilar Sabin, Juli Rifá, Marta Llanos, José Gómez‐Codina, Francisco Lobo, Ramón García, Joaquin Herrero, Mariano Provencio & Carlos Jara. (2007) R‐CHOP‐14 in patients with diffuse large B‐cell lymphoma younger than 70 years: a multicentre, prospective study. Hematological Oncology 26:1, pages 27-32.
Crossref
Florence Broussais-Guillaumot & Bertrand Coiffier. (2007) Strategies for Improving Outcomes with 14-Day Anthracycline- Based Regimens in Patients with Aggressive Lymphomas. Clinical Lymphoma and Myeloma 8, pages S50-S56.
Crossref
Dorte Tholstrup, Peter de Nully Brown, Jesper Jurlander & Mads Hansen. (2007) Feasibility, efficacy and safety of CHOP-14 in elderly patients with very high-risk diffuse large B-cell lymphoma. European Journal of Haematology 79:2, pages 100-106.
Crossref
Ulrich J. M. Mey, Anna Maier, Ingo G. H. Schmidt-Wolf, Carsten Ziske, Helmut Forstbauer, Gamal-Andre Banat, Michael Reber, John W. Strehl & Marcus Gorschlueter. (2007) Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma. Supportive Care in Cancer 15:7, pages 877-884.
Crossref
Thomas M. Habermann. (2007) Antibody Therapy in Aggressive Lymphomas. Hematology 2007:1, pages 257-264.
Crossref
Julio García-Suárez, Helena Bañas, Ignacio Arribas, Dunia De Miguel, Teresa Pascual & Carmen Burgaleta. (2007) Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study. British Journal of Haematology 136:2, pages 276-285.
Crossref
Michael Decker, Christian Rothermundt, Georg Holländer, André Tichelli & Christoph Rochlitz. (2006) Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. The Lancet Oncology 7:8, pages 693-694.
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 23:2, pages 82-89.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.